LIF presented a project at the MINCyT(1) to
get a FONARSEC (2) for the research, development and production of medicines.
FONARSEC is a financial instrument through
which LIF might be able to get funds to improve its capacity of production.
LIF and UNL(3) have signed a public consortium
in which both institutions will work in this project together.
The main objective is firstly, to develop know
how and finally, the production of medicines used in patients with
tuberculosis.
Thus, LIF will be able to produce four
different medicines as:
- Ethambutol.
- Rifampin + Isoniazid (double association).
- Isoniazid.
LIF is going to build a new area for research
and development where new equipment and machines will be incorporated.
In this project,
LIF is going to work during 36 months with other areas of the UNL like:
Laboratorio de Control de Calidad de la Fac. de Bioquímica y Cs. Biológicas; Instituto de Tecnología Celulósica and
Departamento de Ingeniería Industrial de la Facultad de Ingeniería Química.
Once this
objective is reached, LIF will be able to provide these medicines to the
National Government, who has had problems in buying them in the pharmaceutical
market.
(1)MINCyT:
Ministerio de Innovación, Ciencia y Tecnología.
(2)FONARSEC:
Fondo Argentino Sectorial.
(3)UNL:
Universidad Nacional del Litoral
No comments:
Post a Comment